Statistik Asas
| LEI | 5493003JFSMOJG48V108 |
| CIK | 1420798 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Reckitt Benckiser Group plc
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
| September 25, 2020 |
Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.A., represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (Reckitt Benckiser Group plc, 333-223047) that the Commission declared effective, with terms of deposit identical to the terms of deposit of this registration statement. (2) That its ability to designate the date and t |
|
| September 25, 2020 |
As filed with the U.S. Securities and Exchange Commission on September 25, 2020 Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 For Depositary Shares Evidenced by American Depositary Receipts RECKITT BENCKISER GROUP PLC (Exact name of issuer of deposited securities as specified in its charter) n/a (Tra |
|
| September 25, 2020 |
Ziegler, Ziegler & Associates LLP Counselors at Law 570 Lexington Avenue, Suite 2405 New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605 September 25, 2020 JPMorgan Chase Bank, N. |
|
| September 25, 2020 |
J.P.Morgan J.P.Morgan AMENDMENT NO. 1 dated as of , 2020 (the "Amendment"), to the Amended and Restated Deposit Agreement dated as of May 21, 2018 (the "Deposit Agreement") among RECKITT BENCKISER GROUP PLC and its successors (herein called the “Company”), JPMORGAN CHASE BANK, N.A., as depositary hereunder (herein called the “Depositary”), and all holders from time to time of American Depositary R |
|
| May 21, 2018 |
F-6 POS 1 e618027f6pos-rb.htm As filed with the U.S. Securities and Exchange Commission on May 21, 2018 Registration No. 333-223047 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 For Depositary Shares Evidenced by American Depositary Receipts RECKITT BENCKISER GROUP PLC (Exact name of issu |
|
| May 21, 2018 |
J.P.Morgan J.P.Morgan TABLE OF CONTENTS Page PARTIES 1 RECITALS 1 Section 1. Certain Definitions (a) ADR Register 1 (b) ADRs; Direct Registration ADRs 1 (c) ADS 1 (d) Custodian 1 (e) Deliver, execute, issue et al. 1 (f) Delivery Order 1 (g) Deposited Securities 2 (h) Direct Registration System 2 (i) Holder 2 (j) Securities Act of 1933 2 (k) Securities Exchange Act of 1934 2 (l) Shares 2 (m) Transf |
|
| May 21, 2018 |
Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.A., represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (Reckitt Benckiser Group plc, 333-185133) that the Commission declared effective, with terms of deposit identical to the terms of deposit of this registration statement. (2) That its ability to designate the date and t |
|
| February 15, 2018 |
F-6EF 1 e617701f6ef-rbg.htm As filed with the U.S. Securities and Exchange Commission on February 15, 2018 Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 For Depositary Shares Evidenced by American Depositary Receipts RECKITT BENCKISER GROUP PLC (Exact name of issuer of deposited securities as specifi |
|
| February 15, 2018 |
Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.A., represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (Reckitt Benckiser Group plc, 333-185133) that the Commission declared effective, with terms of deposit identical to the terms of deposit of this registration statement. (2) That its ability to designate the date and t |
|
| February 15, 2018 |
No. of ADSs: Number Each ADS represents One-Fifth (1/5) of One Share CUSIP: [?] AMERICAN DEPOSITARY RECEIPT evidencing AMERICAN DEPOSITARY SHARES representing ORDINARY SHARES of RECKITT BENCKISER GROUP PLC (Incorporated under the laws of England and Wales) JPMORGAN CHASE BANK, N.A., a national banking association organized under the laws of the United States of America, as depositary hereunder (th |
|
| February 15, 2018 |
Ziegler, Ziegler & Associates LLP Counselors at Law 570 Lexington Avenue, Suite 2405 New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605 February 15, 2018 JPMorgan Chase Bank, N. |
|
| December 19, 2012 |
RECKITT BENCKISER GROUP PLC - SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) Under the Securities Exchange Act of 1934 (Amendment No. 1) Schiff Nutrition International, Inc. (Name of Issuer) Class A Common Stock, par value $0.01 per share (Title of |
|
| December 17, 2012 |
Reckitt Benckiser Successfully Completes Tender Offer for Shares of Schiff Nutrition QuickLinks - Click here to rapidly navigate through this document Exhibit (a)(5)(viii) Reckitt Benckiser Successfully Completes Tender Offer for Shares of Schiff Nutrition SLOUGH, England—(BUSINESS WIRE)—December 17, 2012. |
|
| December 17, 2012 |
QuickLinks - Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 10, 2012 |
Reckitt Benckiser Employees of Schiff Nutrition International, Inc. Q&A Exhibit (a)(5)(vii) Reckitt Benckiser for Employees of Schiff Nutrition International, Inc. |
|
| December 10, 2012 |
SC TO-T/A 1 a2212099zscto-ta.htm SC TO-T/A QuickLinks - Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 4 to SCHEDULE TO (RULE 14D-100) Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 SCHIFF NUTRITION INTERNATIONAL, INC. (Name of Subject Company) ASCOT A |
|
| December 6, 2012 |
QuickLinks - Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 6, 2012 |
December 6, 2012 VIA E-MAIL Daniel F. Duchovny Special Counsel Office of Mergers & Acquisitions U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-3628 Re: Schiff Nutrition International, Inc. Schedule TO filed November 16, 2012, as amended, by Ascot Acquisition Corp., Reckitt Benckiser LLC and Reckitt Benckiser Group PLC File No. 005-51083 Dear Mr. Duchovny: Referen |
|
| December 3, 2012 |
SHF / Silver Hill Trust 2018-SBC1 / RECKITT BENCKISER GROUP PLC - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Schiff Nutrition International, Inc. (Name of Issuer) Class A Common Stock, Par Value $0.01 Per Share (Title of Class of Securities) 806693107 (CUSIP Number of Class of Securities) Class B Common Stock, Par Value $0.01 Per Share (Title of Class of Securities) None (CUSIP N |
|
| December 3, 2012 |
Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the Shares of Schiff Nutrition International, Inc. |
|
| November 27, 2012 |
QuickLinks - Click here to rapidly navigate through this document Exhibit (a)(1)(ix) Amended and Restated NOTICE OF GUARANTEED DELIVERY For Tender of Shares of Class A Common Stock Class B Common Stock of SCHIFF NUTRITION INTERNATIONAL, INC. |
|
| November 27, 2012 |
QuickLinks - Click here to rapidly navigate through this document Exhibit (a)(1)(x) Amended and Restated Offer To Purchase For Cash All Outstanding Shares of Class A Common Stock Class B Common Stock of SCHIFF NUTRITION INTERNATIONAL, INC. |
|
| November 27, 2012 |
Exhibit (d)(2)(vi) November 16, 2012 Reckitt Benckiser Group plc c/o Reckitt Benckiser LLC Morris Corporate Center IV 399 Interpace Parkway P. |
|
| November 27, 2012 |
QuickLinks - Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 27, 2012 |
Exhibit (a)(1)(xi) Amended and Restated Offer To Purchase For Cash All Outstanding Shares of Common Stock Of SCHIFF NUTRITION INTERNATIONAL, INC. |
|
| November 27, 2012 |
QuickLinks - Click here to rapidly navigate through this document Exhibit (a)(1)(viii) Amended and Restated LETTER OF TRANSMITTAL To Tender Shares of Class A Common Stock Class B Common Stock of SCHIFF NUTRITION INTERNATIONAL, INC. |
|
| November 27, 2012 |
QuickLinks - Click here to rapidly navigate through this document Exhibit (a)(1)(vii) Amended and Restated Offer to Purchase for Cash All Outstanding Shares of Common Stock of SCHIFF NUTRITION INTERNATIONAL, INC. |
|
| November 27, 2012 |
Exhibit (a)(5)(vi) 27 November 2012 Dear Schiff employees, I am Rakesh Kapoor, the CEO of Reckitt Benckiser. |
|
| November 23, 2012 |
Ziegler, Ziegler & Associates LLP Counselors at Law 570 Lexington Avenue, 44th Floor New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605 November 23, 2012 JPMorgan Chase Bank, N. |
|
| November 23, 2012 |
F-6 1 e610225f6-reckitt.htm As filed with the U.S. Securities and Exchange Commission on November 23, 2012 Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 For Depositary Shares Evidenced by American Depositary Receipts RECKITT BENCKISER GROUP PLC (Exact name of issuer of deposited securities as specifi |
|
| November 23, 2012 |
EX-99.(A) 2 e610225ex99-a.htm J.P.Morgan J.P.Morgan TABLE OF CONTENTS Page PARTIES 1 RECITALS 1 Section 1. Certain Definitions (a) ADR Register 1 (b) ADRs; Direct Registration ADR 1 (c) ADS 1 (d) Custodian 1 (e) Deliver, execute, issue et al. 1 (f) Delivery Order 1 (g) Deposited Securities 1 (h) Direct Registration System 1 (i) Holder 2 (j) Securities Act of 1933 2 (k) Securities Exchange Act of 1 |
|
| November 21, 2012 |
Exhibit (d)(2)(iv) EXECUTION COPY November 21, 2012 Reckitt Benckiser LLC Morris Corporate Center IV 399 Interpace Parkway P. |
|
| November 21, 2012 |
SC TO-T/A 1 a2211947zscto-ta.htm SC TO-T/A QuickLinks - Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to SCHEDULE TO (RULE 14D-100) Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 SCHIFF NUTRITION INTERNATIONAL, INC. (Name of Subject Company) ASCOT A |
|
| November 21, 2012 |
RECKITT BENCKISER SIGNS MERGER AGREEMENT TO ACQUIRE SCHIFF NUTRITION Exhibit (a)(5)(v) RECKITT BENCKISER SIGNS MERGER AGREEMENT TO ACQUIRE SCHIFF NUTRITION Slough, England — November 21, 2012 — Reckitt Benckiser Group PLC (“Reckitt Benckiser”) (LSE: RBL) today announces it has signed a definitive merger agreement with Schiff Nutrition International, Inc. |
|
| November 21, 2012 |
Exhibit (d)(2)(iii) EXECUTION COPY November 21, 2012 Reckitt Benckiser LLC Morris Corporate Center IV 399 Interpace Parkway P. |
|
| November 21, 2012 |
Exhibit (d)(1)(ii) EXECUTION VERSION AGREEMENT AND PLAN OF MERGER among Reckitt Benckiser LLC, Ascot Acquisition Corp. |
|
| November 21, 2012 |
Exhibit (d)(2)(v) FINAL FORM OF DIRECTOR AND OFFICER TENDER AND SUPPORT AGREEMENT November 21, 2012 Reckitt Benckiser LLC Morris Corporate Center IV 399 Interpace Parkway P. |
|
| November 16, 2012 |
QuickLinks - Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 16, 2012 |
EX-99.(A)(1)(II) 3 a2211881zex-99a1ii.htm EX-99.(A)(1)(II) QuickLinks - Click here to rapidly navigate through this document Exhibit (a)(1)(ii) LETTER OF TRANSMITTAL To Tender Shares of Class A Common Stock Class B Common Stock of SCHIFF NUTRITION INTERNATIONAL, INC. at $42.00 NET PER SHARE Pursuant to the Offer to Purchase dated November 16, 2012 by ASCOT ACQUISITION CORP., a wholly owned subsidi |
|
| November 16, 2012 |
EX-99.(A)(1)(IV) 5 a2211881zex-99a1iv.htm EX-99.(A)(1)(IV) QuickLinks - Click here to rapidly navigate through this document Exhibit (a)(1)(iv) Offer To Purchase For Cash All Outstanding Shares of Class A Common Stock Class B Common Stock of SCHIFF NUTRITION INTERNATIONAL, INC. at $42.00 NET PER SHARE Pursuant to the Offer to Purchase dated November 16, 2012 by ASCOT ACQUISITION CORP., a wholly ow |
|
| November 16, 2012 |
Exhibit (d)(2)(ii) November [ ], 2012 Reckitt Benckiser LLC Morris Corporate Center IV 399 Interpace Parkway P. |
|
| November 16, 2012 |
EX-99.(A)(1)(V) 6 a2211881zex-99a1v.htm EX-99.(A)(1)(V) Exhibit (a)(1)(v) Offer To Purchase For Cash All Outstanding Shares of Common Stock Of SCHIFF NUTRITION INTERNATIONAL, INC. at $42.00 NET PER SHARE Pursuant to the Offer to Purchase dated November 16, 2012 by ASCOT ACQUISITION CORP., a wholly owned subsidiary of RECKITT BENCKISER LLC, a wholly owned subsidiary of RECKITT BENCKISER GROUP PLC T |
|
| November 16, 2012 |
EX-99.(A)(5)(IV) 9 a2211881zex-99a5iv.htm EX-99.(A)(5)(IV) Exhibit (a)(5)(iv) THOMSON REUTERS STREETEVENTS EDITED TRANSCRIPT RB.L - Reckitt Benckiser plc Tender Offer To Acquire Outstanding Shares Of Schiff Nutrition International, Inc. Conference Call EVENT DATE/TIME: NOVEMBER 16, 2012 / 7:30AM GMT THOMSON REUTERS STREETEVENTS | www.streetevents.com | Contact Us ©2012 Thomson Reuters. All rights |
|
| November 16, 2012 |
Exhibit (a)(1)(vi) This announcement is neither an offer to purchase nor a solicitation of an offer to sell Shares (as defined below), and the provisions herein are subject in their entirety to the provisions of the Offer (as defined below). |
|
| November 16, 2012 |
EX-99.(A)(1)(I) 2 a2211881zex-99a1i.htm EX-99.(A)(1)(I) QuickLinks - Click here to rapidly navigate through this document Exhibit (a)(1)(i) Offer to Purchase for Cash All Outstanding Shares of Common Stock of SCHIFF NUTRITION INTERNATIONAL, INC. at $42.00 Net Per Share by ASCOT ACQUISITION CORP., a wholly-owned subsidiary of RECKITT BENCKISER LLC a wholly-owned subsidiary of RECKITT BENCKISER GROU |
|
| November 16, 2012 |
EX-99.(D)(2)(I) 11 a2211881zex-99d2i.htm EX-99.(D)(2)(I) Exhibit (d)(2)(i) November [ ], 2012 Reckitt Benckiser LLC Morris Corporate Center IV 399 Interpace Parkway P.O. Box 225 Parsippany, NJ 07054-0225 Attention: Kelly Slavitt Ladies and Gentlemen: Reference is made to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended from time to time, the “Merger Agreement”), b |
|
| November 16, 2012 |
EX-99.(D)(1) 10 a2211881zex-99d1.htm EX-99.(D)(1) Exhibit (d)(1) AGREEMENT AND PLAN OF MERGER among Reckitt Benckiser LLC, Ascot Acquisition Corp., Schiff Nutrition International, Inc. and Reckitt Benckiser Group plc (solely for purposes of Section 6.17 hereof) Dated as of November [ ], 2012 TABLE OF CONTENTS Page ARTICLE 1 THE OFFER 2 1.1 The Offer 2 1.2 Company Actions 5 1.3 Directors 6 1.4 Top- |
|
| November 16, 2012 |
EX-99.(A)(1)(III) 4 a2211881zex-99a1iii.htm EX-99.(A)(1)(III) QuickLinks - Click here to rapidly navigate through this document Exhibit (a)(1)(iii) NOTICE OF GUARANTEED DELIVERY For Tender of Shares of Class A Common Stock Class B Common Stock of SCHIFF NUTRITION INTERNATIONAL, INC. at $42.00 NET PER SHARE Pursuant to the Offer to Purchase dated November 16, 2012 by ASCOT ACQUISITION CORP., a whol |
|
| November 16, 2012 |
EX-99.(A)(5)(III) 8 a2211881zex-99a5iii.htm EX-99.(A)(5)(III) Exhibit (a)(5)(iii) RECKITT BENCKISER COMMENCES ALL-CASH TENDER OFFER OF $42 PER SHARE TO ACQUIRE ALL OUTSTANDING SHARES OF SCHIFF NUTRITION Slough, England — November 16, 2012 — Reckitt Benckiser Group PLC (“Reckitt Benckiser”) today announced it has commenced its previously announced tender offer to acquire all of the outstanding shar |
|
| November 15, 2012 |
EX-99.(A)(5)(II) 3 a12-270588ex99da5ii.htm EX-99.(A)(5)(II) Exhibit (a)(5)(ii) 15 November 2012 Dear Colleagues, I wanted to tell you that we have just announced publicly an offer to buy a vitamins, mineral and supplements company called Schiff Nutrition International Inc in the USA. The vitamins, mineral and supplements (VMS) category is the largest consumer health care market in the world, value |
|
| November 15, 2012 |
EX-99.(A)(5)(I) 2 a12-270588ex99da5i.htm EX-99.(A)(5)(I) Exhibit (a)(5)(i) RECKITT BENCKISER TO COMMENCE ALL-CASH TENDER OFFER TO ACQUIRE SCHIFF NUTRITION FOR $42 PER SHARE Acquisition to Provide Reckitt Benckiser a Significant Opportunity to Enter Large and Growing Vitamins, Minerals and Supplements Market Cash Offer Represents 23.5% Percent Premium to Announced Bayer Group Transaction And Tender |
|
| November 15, 2012 |
SC TO-C 1 a12-270588sctoc.htm SC TO-C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (RULE 14D–100) Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 SCHIFF NUTRITION INTERNATIONAL, INC. (Name of Subject Company) ASCOT ACQUISITION CORP. a wholly-owned Subsidiary of RECKITT BENCKISER LLC a wholly-owned Subsidi |
|
| December 16, 2008 |
Certification under Rule 466 The depositary, Deutsche Bank Trust Company Americas, represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (Nordea Bank AB 333-155125) that the Commission declared effective, with terms of deposit identical to the terms of deposit of this registration statement. |
|
| December 16, 2008 |
F-6EF 1 v134928f-6ef.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 For American Depositary Shares Evidenced by American Depositary Receipts Reckitt Benckiser Group PLC (Exact name of Issuer of deposited securities as specified in its charter) England and Wales (Jurisdiction of Incorporation or organization of Issuer) |
|
| December 16, 2008 |
EX-99.A 2 v134928ex99a.htm Number Each American Depositary Share represents One-Fifth of One Share Deutsche Bank Trust Company Americas American Depositary Receipt Evidencing American Depositary Shares For Ordinary Shares of Reckitt Benckiser Group PLC (Incorporated under the laws of England and Wales) Deutsche Bank Trust Company Americas, as Depositary (hereinafter referred to as the Depositary), |
|
| December 16, 2008 |
EX-99.D 3 v134928ex99d.htm Ziegler, Ziegler & Associates LLP Counselors at Law 570 Lexington Avenue, 44th Floor New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605 December 15, 2008 Deutsche Bank Trust Company Americas, as Depositary 60 Wall Street New York, New York 10005 American Depositary Shares evidenced by American Depositary Receipts for deposited shares of the foreign private |
|
| October 10, 2008 |
As filed with the Securities and Exchange Commission on October 10, 2008 Registration No. |
|
| October 10, 2008 |
EX-4 3 reckittbenckiseropinionex4.htm OPINION OF DEPOSITARY'S COUNSEL EXHIBIT 4 Writer’s Direct Dial EMMET, MARVIN & MARTIN, LLP COUNSELLORS AT LAW 120 Broadway New York, New York 10271 (212) 238-3000 (212) 653-1760 Fax: (212) 238-3100 Fax: (212) 653-1730 http://www.emmetmarvin.com 177 MADISON AVENUE MORRISTOWN, NEW JERSEY 07960 (973) 538-5600 FAX: (973) 538-6448 1351 WASHINGTON BOULEVARD STAMFORD |
|
| October 10, 2008 |
EX-1 2 reckittbenckiserreceipt.htm FORM OF RECEIPT AMERICAN DEPOSITARY SHARES (One (1) American Depositary Share represents One-Fifth of One (1/5) Share) THE BANK OF NEW YORK MELLON AMERICAN DEPOSITARY RECEIPT FOR COMMON STOCK, PAR VALUE 2.0667 PENCE EACH, OF RECKITT BENCKISER GROUP PLC (INCORPORATED UNDER THE LAWS OF BRITAIN) The Bank of New York Mellon, as depositary (hereinafter called the “Dep |
|
| January 24, 2008 |
EX-99.(A)(5)(L) 2 w46182a6exv99wxayx5yxly.htm (A)(5)(L) Exhibit (a)(5)(L) January 24, 2008 RECKITT BENCKISER ANNOUNCES COMPLETION OF CASH TENDER OFFER FOR ALL OUTSTANDING SHARES OF ADAMS RESPIRATORY THERAPEUTICS, INC. Reckitt Benckiser Group plc (RB.L) (“Reckitt Benckiser”) announced today that it has completed its previously announced cash tender offer (the “Offer”) for all outstanding shares of |
|
| January 24, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 6 to SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Adams Respiratory Therapeutics, Inc. (Name of Subject Company (Issuer)) Twickenham Inc. an indirect, wholly-owned subsidiary of Reckitt Benckiser Group plc and Reckitt Benckiser Group plc (Names of Fi |
|
| January 18, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 5 to SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Adams Respiratory Therapeutics, Inc. (Name of Subject Company (Issuer)) Twickenham Inc. an indirect, wholly-owned subsidiary of Reckitt Benckiser Group plc and Reckitt Benckiser Group plc (Names of Fi |
|
| January 18, 2008 |
Reckitt Benckiser Acquisition of Adams FAQ Q&A through January 17, 2008 Exhibit (a)(5)(K) Reckitt Benckiser Acquisition of Adams FAQ Q&A through January 17, 2008 If an Adams associate is displaced, would they be eligible for state unemployment? Depending on where you live, you may be eligible to receive both severance and unemployment benefits simultaneously. |
|
| January 11, 2008 |
sctovtza UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 4 to SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Adams Respiratory Therapeutics, Inc. (Name of Subject Company (Issuer)) Twickenham Inc. an indirect, wholly-owned subsidiary of Reckitt Benckiser Group plc and Reckitt Benckiser Group plc (Na |
|
| January 11, 2008 |
Reckitt Benckiser Acquisition of Adams FAQ Q&A through January 10, 2008 Exhibit (a)(5)(J) Reckitt Benckiser Acquisition of Adams FAQ Q&A through January 10, 2008 How much advance notice will we receive? All colleagues impacted will be provided with a minimum of 30 days written notice of termination of employment. |
|
| January 8, 2008 |
sctovtza UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 3 to SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Adams Respiratory Therapeutics, Inc. (Name of Subject Company (Issuer)) Twickenham Inc. an indirect, wholly-owned subsidiary of Reckitt Benckiser Group plc and Reckitt Benckiser Group plc (Na |
|
| January 8, 2008 |
Exhibit (a)(5)(I) January 8, 2008 RECKITT BENCKISER RECEIVES HART-SCOTT-RODINO ANTITRUST CLEARANCE FOR ACQUISITION OF ADAMS RESPIRATORY THERAPEUTICS Reckitt Benckiser Group plc (RB. |
|
| January 4, 2008 |
SC TO-T/A 1 w46000sctovtza.htm SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Adams Respiratory Therapeutics, Inc. (Name of Subject Company (Issuer)) Twickenham Inc. an indirect, wholly-owned subsidiary of Reckitt Benckiser Group plc and |
|
| January 4, 2008 |
Reckitt Benckiser Acquisition of Adams FAQ Q&A through January 2, 2008 EX-99.(A)(5)(H) 2 w46000exv99wxayx5yxhy.htm EX-99.(A)(5)(H) Exhibit (a)(5)(H) Q&A Reckitt Benckiser Acquisition of Adams FAQ Q&A through January 2, 2008 Is it correct to assume that the Respiratory Sales Specialists will only receive the February 2008 Bonus and then no other bonus in 2008? The following bonus will not be granted until 2009? No, those assumptions are not correct. Performance-relate |
|
| December 24, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Adams Respiratory Therapeutics, Inc. (Name of Subject Company (Issuer)) Twickenham Inc. an indirect, wholly-owned subsidiary of Reckitt Benckiser Group plc and Reckitt Benckiser Group plc (Names of Fi |
|
| December 24, 2007 |
Reckitt Benckiser Acquisition of Adams FAQ Q&A through December 21, 2007 EX-99.(A)(5)(G) 2 w45056a1exv99wxayx5yxgy.htm EXHIBIT (A)(5)(G) Reckitt Benckiser Acquisition of Adams FAQ Q&A through December 21, 2007 If an Adams employee is offered a substantially equivalent position within Reckitt, and the Adams employee does not accept the offer, will the employee receive his/her full severance? No. If you are offered a substantially equivalent role and choose not to accept |
|
| December 21, 2007 |
Exhibit (a)(5)(F) December 21, 2007 Reckitt Benckiser Commences Cash Tender Offer for All Outstanding Shares of Adams Respiratory Therapeutics Reckitt Benckiser Group plc (RB. |
|
| December 21, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Adams Respiratory Therapeutics, Inc. (Name of Subject Company (Issuer)) Twickenham Inc. an indirect, wholly-owned subsidiary of Reckitt Benckiser Group plc and Reckitt Benckiser Group plc (Names of Filing Person (Offero |
|
| December 21, 2007 |
Exhibit(a)(1)(A) Offer To Purchase For Cash All Outstanding Shares of Common Stock of ADAMS RESPIRATORY THERAPEUTICS, INC. |
|
| December 21, 2007 |
EX-99.(A)(1)(D) 5 w45056exv99wxayx1yxdy.htm EXHIBIT (A)(1)(D) Exhibit (a)(1)(D) Offer To Purchase For Cash All Outstanding Shares of Common Stock of ADAMS RESPIRATORY THERAPEUTICS, INC. at $60.00 NET PER SHARE Pursuant to the Offer to Purchase dated December 21, 2007 by TWICKENHAM INC. an indirect wholly owned subsidiary of RECKITT BENCKISER GROUP PLC THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT |
|
| December 21, 2007 |
EX-99.(A)(1)(B) 3 w45056exv99wxayx1yxby.htm EXHIBIT (A)(1)(B) Exhibit (a)(1)(B) LETTER OF TRANSMITTAL TO TENDER SHARES OF COMMON STOCK OF ADAMS RESPIRATORY THERAPEUTICS, INC. Pursuant to the Offer to Purchase dated December 21, 2007 by TWICKENHAM INC. an indirect wholly owned subsidiary of RECKITT BENCKISER GROUP PLC THE EXPIRATION DATE AND THE WITHDRAWAL DEADLINE IS 12:00 MIDNIGHT, NEW YORK CITY |
|
| December 21, 2007 |
Exhibit (a)(1)(C) NOTICE OF GUARANTEED DELIVERY For Tender of Shares of Common Stock of ADAMS RESPIRATORY THERAPEUTICS, INC. |
|
| December 21, 2007 |
EX-99.(B) 9 w45056exv99wxby.htm EXHIBIT (B) Exhibit (b) Dated December, 2007 RECKITT BENCKISER TREASURY SERVICES PLC RECKITT BENCKISER GROUP PLC arranged by BARCLAYS CAPITAL with BARCLAYS BANK PLC acting as Agent $2,500,000,000 FACILITY AGREEMENT CONTENTS SECTION 1 INTERPRETATION 1 1. DEFINITIONS AND INTERPRETATION 1 1.1 Definitions 1 1.2 Construction 8 1.3 Third Party Rights 9 SECTION 2 THE FACIL |
|
| December 21, 2007 |
EX-99.(A)(1)(E) 6 w45056exv99wxayx1yxey.htm EXHIBIT (A)(1)(E) Exhibit(a)(1)(E) Offer To Purchase For Cash All Outstanding Shares of Common Stock of ADAMS RESPIRATORY THERAPEUTICS, INC. at $60.00 NET PER SHARE Pursuant to the Offer to Purchase dated December 21, 2007 by TWICKENHAM INC. an indirect wholly owned subsidiary of RECKITT BENCKISER GROUP PLC THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT |
|
| December 21, 2007 |
Exhibit 99.1 POWER OF ATTORNEY THIS POWER OF ATTORNEY is granted on 7th day of December 2007 by RECKITT BENCKISER GROUP PLC (a company registered in England and Wales with number 6270876) whose registered office is at 103-105 Bath Road, Slough, Berkshire SL1 3UH, United Kingdom (the ?Principal?). The Principal hereby appoints each of: WILLIAM RICHARD MORDAN of 399 Interpace Parkway, Parsippany, NJ |
|
| December 21, 2007 |
EX-99.(A)(1)(F) 7 w45056exv99wxayx1yxfy.htm EXHIBIT (A)(1)(F) Exhibit (a)(1)(F) This announcement is neither an offer to purchase nor a solicitation of an offer to sell Shares (as defined below). The Offer (as defined below) is made solely by the Offer to Purchase, dated December 21, 2007, and the related Letter of Transmittal and any amendments or supplements thereto, and is being made to all hol |
|
| December 14, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Adams Respiratory Therapeutics, Inc. (Name of Subject Company (Issuer)) Twickenham Inc. an indirect, wholly-owned subsidiary of Reckitt Benckiser Group plc (Names of Filing Person (Offerors)) Common Stock, $.01 par valu |
|
| December 11, 2007 |
SC TO-C 1 w44336dsctovc.htm SC TO-C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Adams Respiratory Therapeutics, Inc. (Name of Subject Company (Issuer)) Twickenham Inc. an indirect, wholly-owned subsidiary of Reckitt Benckiser Group plc (Names of Filing Person (Of |
|
| December 11, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Adams Respiratory Therapeutics, Inc. (Name of Subject Company (Issuer)) Twickenham Inc. an indirect, wholly-owned subsidiary of Reckitt Benckiser Group plc (Names of Filing Person (Offerors)) Common Stock, $.01 par valu |
|
| December 11, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Adams Respiratory Therapeutics, Inc. (Name of Subject Company (Issuer)) Twickenham Inc. an indirect, wholly-owned subsidiary of Reckitt Benckiser Group plc (Names of Filing Person (Offerors)) Common Stock, $.01 par valu |
|
| December 11, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Adams Respiratory Therapeutics, Inc. (Name of Subject Company (Issuer)) Twickenham Inc. an indirect, wholly-owned subsidiary of Reckitt Benckiser Group plc (Names of Filing Person (Offerors)) Common Stock, $.01 par valu |
|
| December 11, 2007 |
SC TO-C 1 w44336bsctovc.htm SC TO-C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Adams Respiratory Therapeutics, Inc. (Name of Subject Company (Issuer)) Twickenham Inc. an indirect, wholly-owned subsidiary of Reckitt Benckiser Group plc (Names of Filing Person (Of |
